首页 | 本学科首页   官方微博 | 高级检索  
检索        

吡柔吡星膀胱灌注预防膀胱癌术后复发
引用本文:樊耘.吡柔吡星膀胱灌注预防膀胱癌术后复发[J].临床医学,2010,30(3):27-28.
作者姓名:樊耘
作者单位:四川省医学科学院附属四川省人民医院城东病区泌尿外科,成都,641400
摘    要:目的探讨吡柔吡星膀胱内灌注预防膀胱癌术后复发的疗效及安全性。方法52例膀胱癌术后患者分为两组,分别用吡柔吡星(THP组)和卡介苗(BCG组)定期膀胱内灌注,随防13~36个月,观察灌注后肿瘤复发情况及并发症。结果THP组复发率17.9%,不良反应率89.3%;BCG组复发率16.6%,不良反应率79.2%。结论吡柔吡星膀胱灌注预防膀胱癌术后复发有效率与卡介苗相同,是一种安全、有效的药物。

关 键 词:膀胱癌  吡柔吡星  膀胱灌注

Irrigation of bladder by perarubicin on preventing carcinoma of bladder postoperative recrudescence
FAN Yun.Irrigation of bladder by perarubicin on preventing carcinoma of bladder postoperative recrudescence[J].Clinical Medicine,2010,30(3):27-28.
Authors:FAN Yun
Institution:FAN Yun.Department of Urology,the Affiliated Sichuan Provincial People's Hospital of Sichuan Academy of Medical Science,Chengdu 610101,China
Abstract:Objective To investigate the effect and safety of preventing carcinoma of bladder postoperative recrudescence with irrigation of bladder by perarubicin.Methods Fifty-two cases of carcinoma of bladder postoperation were divided into THP group and BCG group,each irrigated regularly with perarubicin and BCG respectively with 13-36 months follow-up.After irrigation,tumor recrudescence and complication were observed.Results The recurrence rate in THP group was 17.9%,side reaction rate was 89.3%.The recurrence ra...
Keywords:Carcinoma of bladder  Perarubicin  Irrigation of bladder  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号